159 related articles for article (PubMed ID: 34904163)
1. Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN.
Atia O; Orlanski-Meyer E; Lujan R; Ledderman N; Greenfeld S; Kariv R; Daher S; Yanai H; Loewenberg Weisband Y; Gabay H; Matz E; Nevo D; Ollech J; Zittan E; Israeli E; Schwartz D; Chowers Y; Dotan I; Turner D
J Crohns Colitis; 2022 Jun; 16(5):796-803. PubMed ID: 34904163
[TBL] [Abstract][Full Text] [Related]
2. Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN.
Atia O; Orlanski-Meyer E; Lujan R; Ledderman N; Greenfeld S; Kariv R; Daher S; Yanai H; Loewenberg Weisband Y; Gabay H; Matz E; Nevo D; Israeli E; Schwartz D; Chowers Y; Dotan I; Turner D
J Crohns Colitis; 2022 Jun; 16(5):778-785. PubMed ID: 34791083
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Biologic Therapies on Rate of Colectomy in Paediatric-onset Ulcerative Colitis - A Population-Based Cohort Study.
Hope E; Kuronen-Stewart C; Wilson DC; Henderson P; Clark C
J Pediatr Surg; 2024 Feb; 59(2):230-234. PubMed ID: 37981545
[TBL] [Abstract][Full Text] [Related]
4. Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort.
Lujan R; Buchuk R; Focht G; Yogev D; Greenfeld S; Ben-Tov A; Weisband YL; Lederman N; Matz E; Ben Horin S; Dotan I; Nevo D; Turner D
Gastroenterology; 2024 May; 166(5):815-825.e22. PubMed ID: 38331205
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN.
Atia O; Magen Rimon R; Ledderman N; Greenfeld S; Kariv R; Loewenberg Weisband Y; Shaoul R; Matz E; Odes S; Goren I; Yanai H; Dotan I; Turner D
Inflamm Bowel Dis; 2024 Feb; 30(2):213-221. PubMed ID: 37084279
[TBL] [Abstract][Full Text] [Related]
6. Incidence Rates and Predictors of Colectomy for Ulcerative Colitis in the Era of Biologics: Results from a Provincial Database.
Abou Khalil M; Boutros M; Nedjar H; Morin N; Ghitulescu G; Vasilevsky CA; Gordon P; Rahme E
J Gastrointest Surg; 2018 Jan; 22(1):124-132. PubMed ID: 28808892
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN.
Atia O; Buchuk R; Lujan R; Greenfeld S; Kariv R; Loewenberg Weisband Y; Lederman N; Matz E; Ledder O; Zittan E; Yanai H; Shwartz D; Freiman M; Dotan I; Nevo D; Turner D
Inflamm Bowel Dis; 2024 May; ():. PubMed ID: 38768390
[TBL] [Abstract][Full Text] [Related]
8. Long term course of ulcerative colitis in the prebiologic era. A retrospective study in a tertiary referral center.
Margagnoni G; Fascì Spurio F; Feigusch L; Koch M; Papi C; Aratari A
Minerva Gastroenterol Dietol; 2014 Dec; 60(4):275-83. PubMed ID: 25384806
[TBL] [Abstract][Full Text] [Related]
9. Trends in Morbidity and Mortality Following Colectomy Among Patients with Ulcerative Colitis in the Biologic Era (2002-2013): A Study Using the National Inpatient Sample.
Olaiya B; Renelus BD; Filon M; Saha S
Dig Dis Sci; 2021 Jun; 66(6):2032-2041. PubMed ID: 32676826
[TBL] [Abstract][Full Text] [Related]
10. Elderly-Onset and Adult-Onset Ulcerative Colitis Are More Similar than Previously Reported in a Nationwide Cohort.
Kumar V; Shah Y; Patel D; Khan N
Dig Dis Sci; 2017 Oct; 62(10):2857-2862. PubMed ID: 28884254
[TBL] [Abstract][Full Text] [Related]
11. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study.
Kaplan GG; Seow CH; Ghosh S; Molodecky N; Rezaie A; Moran GW; Proulx MC; Hubbard J; MacLean A; Buie D; Panaccione R
Am J Gastroenterol; 2012 Dec; 107(12):1879-87. PubMed ID: 23165448
[TBL] [Abstract][Full Text] [Related]
12. Long-term Colectomy Rates of Ulcerative Colitis over 40 Years of Different Therapeutic Eras-Results from a Western Hungarian Population-based Inception Cohort Between 1977 and 2020.
Wetwittayakhlang P; Gonczi L; Lakatos L; Kurti Z; Golovics P; Pandur T; David G; Erdelyi Z; Szita I; Lakatos PL
J Crohns Colitis; 2023 May; 17(5):712-721. PubMed ID: 36539328
[TBL] [Abstract][Full Text] [Related]
13. Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics.
Williet N; Pillot C; Oussalah A; Billioud V; Chevaux JB; Bresler L; Bigard MA; Gueant JL; Peyrin-Biroulet L
Inflamm Bowel Dis; 2012 Sep; 18(9):1641-6. PubMed ID: 22139830
[TBL] [Abstract][Full Text] [Related]
14. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
Schmidt KJ; Müller N; Dignass A; Baumgart DC; Lehnert H; Stange EF; Herrlinger KR; Fellermann K; Büning J
J Crohns Colitis; 2016 Jan; 10(1):31-7. PubMed ID: 26419459
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
[TBL] [Abstract][Full Text] [Related]
16. Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis.
Yuan W; Marwaha JS; Rakowsky ST; Palmer NP; Kohane IS; Rubin DT; Brat GA; Feuerstein JD
Inflamm Bowel Dis; 2023 May; 29(5):695-704. PubMed ID: 35786768
[TBL] [Abstract][Full Text] [Related]
17. A population-based nationwide study on total colectomy for ulcerative colitis and risk of ten prevalent inflammatory or autoimmune diseases.
Mark-Christensen A; Jølving LR; Anru PL; Murray JA; Nielsen RG; Qvist N; Laurberg S; Engberg H; Kjeldsen J; Nørgård BM
Scand J Gastroenterol; 2023; 58(12):1398-1404. PubMed ID: 37415465
[TBL] [Abstract][Full Text] [Related]
18. Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, Scotland.
Jenkinson PW; Plevris N; Lyons M; Grant R; Fulforth J; Kirkwood K; Arnott ID; Wilson D; Watson AJM; Jones GR; Lees CW
Colorectal Dis; 2021 May; 23(5):1175-1183. PubMed ID: 33350054
[TBL] [Abstract][Full Text] [Related]
19. Time trend in surgical indications and outcomes in ulcerative colitis-A two decades in-depth retrospective analysis.
Le Cosquer G; Capirchio L; Rivière P; Denis MA; Poullenot F; Remue C; Zerbib F; Leonard D; Célérier B; Kartheuser A; Laharie D; Dewit O
Dig Liver Dis; 2023 Oct; 55(10):1338-1344. PubMed ID: 37029063
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study.
Han M; Jung YS; Cheon JH; Park S
Yonsei Med J; 2020 Jan; 61(1):48-55. PubMed ID: 31887799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
